ID

17699

Description

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00409760

Lien

https://clinicaltrials.gov/show/NCT00409760

Mots-clés

Versions (1)
  1. 28/09/2016 28/09/2016 -
Téléchargé le

28 septembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hypertension NCT00409760

Anglais

Eligibility Hypertension NCT00409760

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
outpatients 18 years and older.
Description

Outpatients | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
male or female patients are eligible.
Description

Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
female patients must be either post-menopausal for one year or surgically sterile, or using effective contraceptive methods such as barrier method with spermicide or an intra-uterine device. hormonal contraceptive use is disallowed.
Description

Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Contraception, Barrier | Vaginal Spermicides | Intrauterine Devices | Contraceptives, Oral, Hormonal

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0015787
UMLS CUI [4]
C0700589
UMLS CUI [5]
C0004764
UMLS CUI [6]
C0087145
UMLS CUI [7]
C0021900
UMLS CUI [8]
C0009907
patients with mild to moderate essential diastolic hypertension (grades 1 and 2 who classification) measured by calibrated standard sphygmomanometer.
Description

essential diastolic hypertension Mild | essential diastolic hypertension Moderate | Measurement Sphygmomanometer Standard

Type de données

boolean

Alias
UMLS CUI [1,1]
C3694763
UMLS CUI [1,2]
C2945599
UMLS CUI [2,1]
C3694763
UMLS CUI [2,2]
C0205081
UMLS CUI [3,1]
C0242485
UMLS CUI [3,2]
C0183427
UMLS CUI [3,3]
C1442989
patients must have a msdbp >= 90 mmhg and < 110 mmhg at visit 1 (week -2 to -4), and a msdbp >= 95 mmhg and < 110 mmhg at visit 2 (week 0).
Description

Sitting diastolic blood pressure mean visit 1 | Sitting diastolic blood pressure mean visit 2

Type de données

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [1,3]
C3842539
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [2,3]
C3842538
patients must have an absolute difference of =< 10 mmhg in their average sitting diastolic blood pressure between visits 1 and 2.
Description

Sitting diastolic blood pressure Average | Difference Absolute visit 1 visit 2

Type de données

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C1510992
UMLS CUI [2,1]
C1705242
UMLS CUI [2,2]
C0205344
UMLS CUI [2,3]
C3842539
UMLS CUI [2,4]
C3842538
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written informed consent).
Description

Compliance behavior | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension (grade 3 who classification; msdbp >=110 mmhg diastolic and/or mssbp >= 180 mmhg systolic).
Description

Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Type de données

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
inability to discontinue all prior anti-hypertensive medications safely for a period of 14 weeks).
Description

Antihypertensive Agents Discontinue Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
known keith-wagener grade iii or iv hypertensive retinopathy.
Description

Retinopathy hypertensive grade 3 | Retinopathy hypertensive grade 4

Type de données

boolean

Alias
UMLS CUI [1]
C0857534
UMLS CUI [2]
C0857415
history of hypertensive encephalopathy or cerebrovascular accident at anytime prior to visit 1 (week -2 to -4).
Description

Hypertensive Encephalopathy | Cerebrovascular accident

Type de données

boolean

Alias
UMLS CUI [1]
C0151620
UMLS CUI [2]
C0038454
transient ischemic cerebral attack during the last 12 months prior to visit 1 (week-2 to -4).
Description

Transient Ischemic Attack

Type de données

boolean

Alias
UMLS CUI [1]
C0007787
evidence of a secondary form of hypertension, such as coarctation of the aorta, hyperaldosteronism, unilateral renal artery stenosis, or pheochromocytoma, etc.
Description

Secondary hypertension Evidence of | Aortic coarctation | Hyperaldosteronism | Unilateral renal artery stenosis | Pheochromocytoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0155616
UMLS CUI [1,2]
C0332120
UMLS CUI [2]
C0003492
UMLS CUI [3]
C0020428
UMLS CUI [4]
C0856759
UMLS CUI [5]
C0031511
type 1 diabetes mellitus.
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
type 2 diabetes mellitus with poor glucose control as defined by fasting glycosylated hemoglobin (hba1c) >8% at visit 1 (week -2 to -4).
Description

Diabetes Mellitus, Non-Insulin-Dependent | GLUCOSE CONTROL Poor | Glycosylated hemoglobin A Fasting

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0726398
UMLS CUI [2,2]
C0542537
UMLS CUI [3,1]
C0019018
UMLS CUI [3,2]
C0015663
administration of any agent indicated for the treatment of hypertension within a minimum 4 weeks prior to randomization into the study (visit 2, week 0), with the permitted exception of those anti-hypertensive medications requiring tapering down commencing at visit 0 (week -4 to -6).
Description

Antihypertensive Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0003364
known or suspected contraindications, including history of allergy to angiotensin receptor blockers or calcium channel blockers.
Description

Medical contraindication | Hypersensitivity Angiotensin II receptor antagonist | Hypersensitivity Calcium Channel Blockers

Type de données

boolean

Alias
UMLS CUI [1]
C1301624
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0521942
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0006684
other protocol-defined inclusion/exclusion criteria may apply
Description

Inclusion criteria Study Protocol | Exclusion Criteria Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348563
UMLS CUI [2,1]
C0680251
UMLS CUI [2,2]
C2348563
Retour au début de la page

Similar models

Eligibility Hypertension NCT00409760

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age
Item
outpatients 18 years and older.
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender
Item
male or female patients are eligible.
boolean
C0079399 (UMLS CUI [1])
Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Contraception, Barrier | Vaginal Spermicides | Intrauterine Devices | Contraceptives, Oral, Hormonal
Item
female patients must be either post-menopausal for one year or surgically sterile, or using effective contraceptive methods such as barrier method with spermicide or an intra-uterine device. hormonal contraceptive use is disallowed.
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
C0004764 (UMLS CUI [5])
C0087145 (UMLS CUI [6])
C0021900 (UMLS CUI [7])
C0009907 (UMLS CUI [8])
essential diastolic hypertension Mild | essential diastolic hypertension Moderate | Measurement Sphygmomanometer Standard
Item
patients with mild to moderate essential diastolic hypertension (grades 1 and 2 who classification) measured by calibrated standard sphygmomanometer.
boolean
C3694763 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C3694763 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0242485 (UMLS CUI [3,1])
C0183427 (UMLS CUI [3,2])
C1442989 (UMLS CUI [3,3])
Sitting diastolic blood pressure mean visit 1 | Sitting diastolic blood pressure mean visit 2
Item
patients must have a msdbp >= 90 mmhg and < 110 mmhg at visit 1 (week -2 to -4), and a msdbp >= 95 mmhg and < 110 mmhg at visit 2 (week 0).
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C3842539 (UMLS CUI [1,3])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C3842538 (UMLS CUI [2,3])
Sitting diastolic blood pressure Average | Difference Absolute visit 1 visit 2
Item
patients must have an absolute difference of =< 10 mmhg in their average sitting diastolic blood pressure between visits 1 and 2.
boolean
C1319894 (UMLS CUI [1,1])
C1510992 (UMLS CUI [1,2])
C1705242 (UMLS CUI [2,1])
C0205344 (UMLS CUI [2,2])
C3842539 (UMLS CUI [2,3])
C3842538 (UMLS CUI [2,4])
Compliance behavior | Informed Consent
Item
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written informed consent).
boolean
C1321605 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
severe hypertension (grade 3 who classification; msdbp >=110 mmhg diastolic and/or mssbp >= 180 mmhg systolic).
boolean
C4013784 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive Agents Discontinue Unable
Item
inability to discontinue all prior anti-hypertensive medications safely for a period of 14 weeks).
boolean
C0003364 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Retinopathy hypertensive grade 3 | Retinopathy hypertensive grade 4
Item
known keith-wagener grade iii or iv hypertensive retinopathy.
boolean
C0857534 (UMLS CUI [1])
C0857415 (UMLS CUI [2])
Hypertensive Encephalopathy | Cerebrovascular accident
Item
history of hypertensive encephalopathy or cerebrovascular accident at anytime prior to visit 1 (week -2 to -4).
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Transient Ischemic Attack
Item
transient ischemic cerebral attack during the last 12 months prior to visit 1 (week-2 to -4).
boolean
C0007787 (UMLS CUI [1])
Secondary hypertension Evidence of | Aortic coarctation | Hyperaldosteronism | Unilateral renal artery stenosis | Pheochromocytoma
Item
evidence of a secondary form of hypertension, such as coarctation of the aorta, hyperaldosteronism, unilateral renal artery stenosis, or pheochromocytoma, etc.
boolean
C0155616 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0003492 (UMLS CUI [2])
C0020428 (UMLS CUI [3])
C0856759 (UMLS CUI [4])
C0031511 (UMLS CUI [5])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus.
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | GLUCOSE CONTROL Poor | Glycosylated hemoglobin A Fasting
Item
type 2 diabetes mellitus with poor glucose control as defined by fasting glycosylated hemoglobin (hba1c) >8% at visit 1 (week -2 to -4).
boolean
C0011860 (UMLS CUI [1])
C0726398 (UMLS CUI [2,1])
C0542537 (UMLS CUI [2,2])
C0019018 (UMLS CUI [3,1])
C0015663 (UMLS CUI [3,2])
Antihypertensive Agents
Item
administration of any agent indicated for the treatment of hypertension within a minimum 4 weeks prior to randomization into the study (visit 2, week 0), with the permitted exception of those anti-hypertensive medications requiring tapering down commencing at visit 0 (week -4 to -6).
boolean
C0003364 (UMLS CUI [1])
Medical contraindication | Hypersensitivity Angiotensin II receptor antagonist | Hypersensitivity Calcium Channel Blockers
Item
known or suspected contraindications, including history of allergy to angiotensin receptor blockers or calcium channel blockers.
boolean
C1301624 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0006684 (UMLS CUI [3,2])
Inclusion criteria Study Protocol | Exclusion Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0680251 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial